BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Ocugen to Participate in Upcoming August 2026 Investor Conferences

  July 31, 2026

   · 

  3 min read
• Press Releases

  Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation

  July 31, 2026

   · 

  3 min read
• Press Releases

  INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th

  July 31, 2026

   · 

  4 min read
• Press Releases

  Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

  July 31, 2026

   · 

  7 min read
• Press Releases

  INmune Bio Receives R&D Rebates of Approximately $4.6 Million

  July 31, 2026

   · 

  5 min read
• Press Releases

  Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates

  July 31, 2026

   · 

  8 min read
• Press Releases

  Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

  July 31, 2026

   · 

  5 min read
• Press Releases

  Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab

  July 31, 2026

   · 

  6 min read
• Press Releases

  Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates

  July 31, 2026

   · 

  14 min read
• Press Releases

  Ractigen Therapeutics Announces U.S. FDA IND Clearance for First-in-Class saRNA Candidate RAG-1C to Treat Proliferative Vitreoretinopathy

  July 31, 2026

   · 

  4 min read